Leukocyte migration in response to cell attractant gradients or chemotaxis is a key phenomenon both in cell movement and in the inflammatory response. Chemokines are quite likely to be the key molecules directing migration of leukocytes that involve cell polarization with generation of specialized cell compartments. The precise mechanism of leukocyte chemoattraction is not known, however. In this study, we demonstrate that the CC chemokine receptors CCR2 and CCR5, but not cytokine receptors such as interleukin (IL)-2Rα, IL-2Rβ, tumor necrosis factor receptor 1, or transforming growth factor βR, are redistributed to a pole in T cells that are migrating in response to chemokines. Immunofluorescence and confocal microscopy studies show that the chemokine receptors concentrate at the leading edge of the cell on the flattened cell-substratum contact area, induced specifically by the signals that trigger cell polarization. The redistribution of chemokine receptors is blocked by pertussis toxin and is dependent on cell adhesion through integrin receptors, which mediate cell migration. Chemokine receptor expression on the leading edge of migrating polarized lymphocytes appears to act as a sensor mechanism for the directed migration of leukocytes through a chemoattractant gradient.
Skip Nav Destination
Article navigation
7 July 1997
Article Contents
Brief Definitive Report|
July 07 1997
Polarization of Chemokine Receptors to the Leading Edge during Lymphocyte Chemotaxis
Marta Nieto,
Marta Nieto
From the *Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, E-28006, Madrid, Spain; and ‡Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Search for other works by this author on:
José M.R. Frade,
José M.R. Frade
From the *Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, E-28006, Madrid, Spain; and ‡Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Search for other works by this author on:
David Sancho,
David Sancho
From the *Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, E-28006, Madrid, Spain; and ‡Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Search for other works by this author on:
Mario Mellado,
Mario Mellado
From the *Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, E-28006, Madrid, Spain; and ‡Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Search for other works by this author on:
Carlos Martinez-A,
Carlos Martinez-A
From the *Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, E-28006, Madrid, Spain; and ‡Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Search for other works by this author on:
Francisco Sánchez-Madrid
Francisco Sánchez-Madrid
From the *Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, E-28006, Madrid, Spain; and ‡Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Search for other works by this author on:
Marta Nieto
,
José M.R. Frade
,
David Sancho
,
Mario Mellado
,
Carlos Martinez-A
,
Francisco Sánchez-Madrid
From the *Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, E-28006, Madrid, Spain; and ‡Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, Universidad Autónoma de Madrid, Campus de Cantoblanco, E-28049 Madrid, Spain
Address correspondence to Francisco Sánchez-Madrid Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Diego de León 62, E-28006, Madrid, Spain. Phone: 34-1-402-3347; FAX: 34-1-309-2496; E-mail: fsmadrid/[email protected]
Received:
January 15 1997
Revision Received:
April 18 1997
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 186 (1): 153–158.
Article history
Received:
January 15 1997
Revision Received:
April 18 1997
Citation
Marta Nieto, José M.R. Frade, David Sancho, Mario Mellado, Carlos Martinez-A, Francisco Sánchez-Madrid; Polarization of Chemokine Receptors to the Leading Edge during Lymphocyte Chemotaxis. J Exp Med 7 July 1997; 186 (1): 153–158. doi: https://doi.org/10.1084/jem.186.1.153
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement